STOCK TITAN

Zai Lab: RA Capital reports 2.5% passive stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Zai Lab Ltd's ordinary shares are reported as beneficially owned by RA Capital Management, L.P., RA Capital Healthcare Fund, L.P., Peter Kolchinsky and Rajeev Shah: each reports 28,155,430 shares, or 2.5% of the class, as of September 30, 2026. These are reports of the same share block, not four separate holdings. The Fund directly holds 2,815,543 ADSs, each representing 10 ordinary shares. The Fund delegated voting and disposition power over the securities to RA Capital and states it cannot revoke that delegation on less than 61 days' notice. The reporting persons also report shared voting and dispositive power; the Fund and the other reporting persons disclose their respective disclaimers of beneficial ownership for Section 13(d) purposes.

Beneficially owned ordinary shares 28,155,430 ordinary shares Reported by each of the four reporting persons as of September 30, 2026; the reports concern the same share block.
Percentage of class 2.5% Reported as of September 30, 2026; based on 1,122,662,280 ordinary shares outstanding as of July 31, 2026.
ADSs held directly by the Fund 2,815,543 ADSs The Fund's direct holding, representing 28,155,430 ordinary shares.
ADS ratio 10 ordinary shares per ADS Each ADS represents 10 ordinary shares.
Ordinary shares outstanding 1,122,662,280 ordinary shares As of July 31, 2026; the stated basis for the reported percentage of class.
American Depositary Shares technical
"The Fund directly holds 2,815,543 American Depositary Shares"
American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.
beneficial ownership regulatory
"Aggregate Amount Beneficially Owned by Each Reporting Person"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
shared voting power regulatory
"Shared Voting Power 28,155,430.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Section 13(d) regulatory
"for purposes of Section 13(d) of the Act"
A Section 13(d) filing is a public disclosure required under U.S. securities law when a person or group acquires more than 5% of a company’s registered equity and may influence control. The filer must report who owns the shares, how they were acquired, and any plans or intentions for the company, so the market and other shareholders can see if a large buyer is attempting a takeover or other strategic move. Think of it like a formal announcement that someone has crossed a threshold and is showing their hand.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ZLAB ordinary shares did the reporting persons report?

Each of the four reporting persons reported beneficial ownership of 28,155,430 ordinary shares, or 2.5% of the class, as of September 30, 2026. The reports concern the same share block, not four separate holdings.

Who has voting and disposition power over ZLAB shares?

The Fund delegated sole voting and disposition power over its portfolio securities to RA Capital. Each reporting person's cover page reports shared voting and dispositive power over 28,155,430 ordinary shares. The Fund states that it cannot revoke the delegation on less than 61 days' notice.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





98887Q104

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



RA Capital Management, L.P.
Signature:/s/ Peter Kolchinsky
Name/Title:By Peter Kolchinsky, Authorized Signatory
Date:11/16/2026
Peter Kolchinsky
Signature:/s/ Peter Kolchinsky
Name/Title:Peter Kolchinsky
Date:11/16/2026
Rajeev Shah
Signature:/s/ Rajeev Shah
Name/Title:Rajeev Shah
Date:11/16/2026
RA Capital Healthcare Fund, L.P.
Signature:/s/ Peter Kolchinsky
Name/Title:By RA Capital Healthcare Fund GP, LLC, its General Partner, By Peter Kolchinsky, Manager
Date:11/16/2026
Exhibit Information

Exhibit 99.1 Joint Filing Agreement (incorporated by reference to Exhibit 99.1 to the Reporting Persons' Schedule 13G filed with the SEC on April 6, 2026).

Keep reading